Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors from the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations analyze identified that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid pepti... https://jackiel589tls8.livebloggs.com/profile